Market cap
$549.7M

Anbio Biotechnology (NNNN) is a Biotechnology: In Vitro & In Vivo Diagnostic Substances company listed on NASDAQ. There were no new wire items for NNNN in the last 30 days. The most recent was published Jul 9, 2026.

Financial highlights

Full financials
Revenue, FY2025
$8.65M
Revenue growth
+5.6%
Net income, FY2025
$6.40M
Net margin
74.1%
Cash
$7.77M

For fiscal 2025 (ended Dec 31, 2025), from SEC filings. Not investment advice.

News · 26 weeks30%
2026-05-24: 02026-05-31: 02026-06-07: 22026-06-14: 02026-06-21: 02026-06-28: 02026-07-05: 12026-07-12: 02026-07-19: 02026-07-26: 02026-08-02: 02026-08-09: 02026-08-16: 02026-08-23: 02026-08-30: 02026-09-06: 02026-09-13: 02026-09-20: 02026-09-27: 02026-10-04: 02026-10-11: 02026-10-18: 02026-10-25: 02026-11-01: 02026-11-08: 02026-11-15: 0
2026-05-242026-11-15
Mix090d

No activity.

Activity · 52 weeks1610 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

22 items

NNNN FAQ

9 questions
  • What is the latest news on NNNN?
    Quantisnow has not tracked any new filings, ratings or press releases for NNNN in the last 30 days. The most recent wire item was published on July 9, 2026.
  • What is NNNN revenue?
    Anbio Biotechnology (NNNN) reported $8.65M of revenue for fiscal 2025 (ended Dec 31, 2025). That is up 5.6% from the year before.
  • Is NNNN profitable?
    Yes. Anbio Biotechnology earned $6.40M in net income for fiscal 2025 (ended Dec 31, 2025), a net margin of 74.1%.
  • How much cash and debt does NNNN have?
    Anbio Biotechnology reported $7.77M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does NNNN stock trade?
    Anbio Biotechnology (NNNN) is listed on NASDAQ.
  • What sector and industry is NNNN in?
    Anbio Biotechnology operates in the Health Care sector, Biotechnology: In Vitro & In Vivo Diagnostic Substances industry.
  • When did Anbio Biotechnology go public?
    Anbio Biotechnology (NNNN) completed its IPO in 2025.
  • What companies are similar to NNNN?
    Notable peers in the same industry include NTLA (Intellia Therapeutics Inc.), LNTH (Lantheus Holdings Inc.), ACHV (Achieve Life Sciences Inc.), ORKA (Oruka Therapeutics Inc.), CLDX (Celldex Therapeutics Inc.). Compare NNNN side-by-side with any of them on Quantisnow.
  • How can I track NNNN on Quantisnow?
    Quantisnow aggregates Anbio Biotechnology's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NNNN to receive live email and push alerts on every new disclosure.